312 related articles for article (PubMed ID: 11141472)
1. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
Gronert K; Martinsson-Niskanen T; Ravasi S; Chiang N; Serhan CN
Am J Pathol; 2001 Jan; 158(1):3-9. PubMed ID: 11141472
[TBL] [Abstract][Full Text] [Related]
2. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
Fierro IM; Colgan SP; Bernasconi G; Petasis NA; Clish CB; Arita M; Serhan CN
J Immunol; 2003 Mar; 170(5):2688-94. PubMed ID: 12594298
[TBL] [Abstract][Full Text] [Related]
3. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
Qiu FH; Devchand PR; Wada K; Serhan CN
FASEB J; 2001 Dec; 15(14):2736-8. PubMed ID: 11687510
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
[TBL] [Abstract][Full Text] [Related]
5. Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors.
McMahon B; Stenson C; McPhillips F; Fanning A; Brady HR; Godson C
J Biol Chem; 2000 Sep; 275(36):27566-75. PubMed ID: 10869343
[TBL] [Abstract][Full Text] [Related]
6. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile.
Schottelius AJ; Giesen C; Asadullah K; Fierro IM; Colgan SP; Bauman J; Guilford W; Perez HD; Parkinson JF
J Immunol; 2002 Dec; 169(12):7063-70. PubMed ID: 12471142
[TBL] [Abstract][Full Text] [Related]
7. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation.
Chiang N; Fierro IM; Gronert K; Serhan CN
J Exp Med; 2000 Apr; 191(7):1197-208. PubMed ID: 10748237
[TBL] [Abstract][Full Text] [Related]
8. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
Ariel A; Chiang N; Arita M; Petasis NA; Serhan CN
J Immunol; 2003 Jun; 170(12):6266-72. PubMed ID: 12794159
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.
Chiang N; Gronert K; Clish CB; O'Brien JA; Freeman MW; Serhan CN
J Clin Invest; 1999 Aug; 104(3):309-16. PubMed ID: 10430612
[TBL] [Abstract][Full Text] [Related]
10. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
[TBL] [Abstract][Full Text] [Related]
11. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors.
Brink C; Dahlén SE; Drazen J; Evans JF; Hay DW; Nicosia S; Serhan CN; Shimizu T; Yokomizo T
Pharmacol Rev; 2003 Mar; 55(1):195-227. PubMed ID: 12615958
[TBL] [Abstract][Full Text] [Related]
12. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.
Hachicha M; Pouliot M; Petasis NA; Serhan CN
J Exp Med; 1999 Jun; 189(12):1923-30. PubMed ID: 10377187
[TBL] [Abstract][Full Text] [Related]
13. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo.
Clish CB; O'Brien JA; Gronert K; Stahl GL; Petasis NA; Serhan CN
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8247-52. PubMed ID: 10393980
[TBL] [Abstract][Full Text] [Related]
14. Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability.
Serhan CN; Takano T; Clish CB; Gronert K; Petasis N
Adv Exp Med Biol; 1999; 469():287-93. PubMed ID: 10667343
[No Abstract] [Full Text] [Related]
15. A novel rat lipoxin A4 receptor that is conserved in structure and function.
Chiang N; Takano T; Arita M; Watanabe S; Serhan CN
Br J Pharmacol; 2003 May; 139(1):89-98. PubMed ID: 12746227
[TBL] [Abstract][Full Text] [Related]
16. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.
Planagumà A; Domenech T; Jover I; Ramos I; Sentellas S; Malhotra R; Miralpeix M
Clin Exp Immunol; 2013 Aug; 173(2):298-309. PubMed ID: 23607720
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
Wan M; Godson C; Guiry PJ; Agerberth B; Haeggström JZ
FASEB J; 2011 May; 25(5):1697-705. PubMed ID: 21307335
[TBL] [Abstract][Full Text] [Related]
18. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation.
Clish CB; Levy BD; Chiang N; Tai HH; Serhan CN
J Biol Chem; 2000 Aug; 275(33):25372-80. PubMed ID: 10837478
[TBL] [Abstract][Full Text] [Related]
19. Lipoxins and aspirin-triggered lipoxins in airway responses.
Levy BD; De Sanctis GT; Devchand PR; Kim E; Ackerman K; Schmidt B; Szczeklik W; Drazen JM; Serhan CN
Adv Exp Med Biol; 2003; 525():19-23. PubMed ID: 12751730
[TBL] [Abstract][Full Text] [Related]
20. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.
József L; Zouki C; Petasis NA; Serhan CN; Filep JG
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13266-71. PubMed ID: 12235371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
